Clinical Trial Update: Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating switching to Genvoya, followed by HCV therapy with Epclusa, and subsequent simplification to Biktarvy in HIV-HCV coinfected pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids
• HIV Infection
• Hcv Coinfection
• Hepatitis C

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Epclusa (sofosbuvir/velpatasvir)
• Genvoya (elvitegravir; cobicistat; emtricitabine; tenofovir alafenamide)

Snippet

Sponsor: Saskatchewan Health Authority - Regina Area | Conditions: HIV-1-infection, Hepatitis C, Chronic | Phase 4 | Status: UNKNOWN